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Replication defective viral vectors provide a potentially usecated that even in the absence of a T cell response high ful means of gene transfer to oligodendrocytes and thus viral titres of ⌬E1/E3 adenoviral vectors had a profound for studying the pathogenesis of white matter disease. In cytopathic effect leading to death of oligodendrocytes and this study we have examined the expression pattern of hence demyelination. A similar cytopathic effect was dem-E1/E3 deleted adenoviral vectors expressing the reporter onstrated using an adenoviral vector expressing the neurogene LacZ (AdlacZ) as a means of establishing the value cytokine ciliary neurotrophic factor (AdCNTF). As the titre of these vectors for gene delivery to oligodendrocytes in of injected virus was decreased there was a significant adult rat white matter. Our results indicate that although decrease in the number of transgene expressing cells. such an approach can be used to induce transgene These experiments therefore indicated that in immunoexpression in oligodendrocytes, it is complicated by both deficient recipients there is a narrow window of virus titre immunogenic and cytopathic effects. Thus, in normal anithat results in a high rate of infectivity and expression withmals, injection of ⌬E1/E3 adenoviral vectors was associaout significant cytopathic consequences. At higher viral ted with a robust immune response that led to a lack of titres the cytopathic effects include oligodendrocyte death expression by 40 days after injection. In order to overcome and demyelination, while at lower titres there is a significantIntroduction Replication-defective viral vectors provide a potentially useful means of gene transfer for studying the pathogenesis of white matter disease, or for correcting genetic defects of oligodendrocytes that underlie inherited demyelinating diseases such as the leucodystrophies. For example, such vectors might be used to test hypotheses regarding the role of particular molecules in mediating demyelination or in orchestrating the repair process of remyelination. A variety of virus families, including oncoretroviruses and lentiviruses, adenoviruses, adenoassociated viruses and herpes viruses, has been used in the construction of vectors. [1] [2] [3] Of these, the adenoviruses have attracted particular interest in the context of gene transfer to the CNS on account of their ability to infect non-dividing cells and hence infect neurons. [4] [5] [6] [7] [8] This same property makes adenoviruses suitable vectors for gene delivery to the other non-dividing cell of the CNS, the oligodendrocyte. However, it has become apparent in recent years that adenoviral vectors are immunogenic and can induce cytopathic effects. [9] [10] [11] [12] [13] In this study we have assessed the potential value of replication-defective adenoviral vectors for gene delivery to oligodendrocytes in vivo by examining the effects of virus following injection into white matter tracts of the adult rat spinal cord. We have used first generation (⌬E1/E3) adenoviral vectors expressing either the marker gene LacZ, encoding for Escherichia coli ␤-galactosidase, or expressing a gene for ciliary neurotrophic factor (CNTF), a neurocytokine with a potential role in oligodendrocyte biology. 14, 15 By injecting virus into both immunocompetent and lymphocyte-deficient athymic ('nude') rats we have shown: (1) that adenoviral vectors can efficiently transduce oligodendrocytes in vivo, but that they elicit a strong immune response in normal white matter; and (2) that, even in the absence of an immune response, there is a narrow band of viral dosage below which there is poor transgene expression and above which there are vector-induced cytopathic effects on oligodendrocytes leading to demyelination.
Results
Injection of LacZ-expressing ⌬E1/E3 adenoviral vector (AdlacZ) in white matter of normal rats In the first experiment, 1 l of a solution of virus was injected into the dorsal funiculus of adult Sprague-Dawley rats (Table 1 , group 1). At 4 days post-injection (dpi) a n = 2, otherwise n = 1.
labelled blue cells were detected within the spinal cord over a distance of at least 6 mm. Close to the point of injection large numbers of blue cells were present in the dorsal funiculus ( Figure 1 ) including oligodendrocytes, supporting an earlier observation by Davidson and coworkers. 6 In these cells, blue reaction product was present within the nucleus (where it was especially intense on account of the adenoviral construct containing a nuclear localisation signal) and to a lesser extent within the cytoplasm and processes (Figures 2 and 3) . Labelled oligodendrocytes were also identifiable ultrastructurally by virtue of the characteristic electron dense reaction product clustered over the nucleus and within the cytoplasm (Figure 4) . 16 This indicated that oligodendrocytes were readily infected with the adenoviral vector and that there was robust expression of the adenoviral LacZ gene. In addition to oligodendrocyte labelling there was labelling of astrocytes (identified by co-labelling by immunostaining with GFAP antibodies) ( Figure 5 ). Some of the viral vector solution was also injected into grey matter. In this region blue reaction product was identified within ependymal cells and neurons, particularly in the ventral horn where there was also labelling of their associated intramedullary and ventral root axons (Figures 6 and 7) . Although endogenous ␤-galactosidase is expressed in ventral motor neurons and can account for false positive labelling, 17 the intense nature of the blue precipitate and the blue staining of the nucleus enabled E. coli LacZexpressing cells to be easily distinguished from those labelled due to endogenous expression. In the toluidine blue-stained sections small numbers of lymphocytes were present as perivascular cuffs.
At 7 dpi a similar pattern of labelled cells was observed over a greater longitudinal distance (Ͼ10 mm). However, the lymphocyte response was more extensive (Figure 8 ). By 21 dpi only a few blue cells could be detected in a single 1 mm block and there was evidence of an extensive immune cell response that was associated with widespread damage to both the white and grey matter ( Figure 9 ). At 40 dpi no blue cells were present and there was evidence of a residual immune response. The presence of both oligodendrocyte and Schwann cell remyelination at this stage indicated that astrocyte as well as oligodendrocyte injury had occurred since Schwann cell remyelination of demyelinated CNS axons occurs in areas where astrocytes are damaged. 18 The presence of Wallerian degeneration in the dorsal funiculus within sections taken from cranial blocks indicated that there had also been axonal loss.
AdlacZ in white matter of immune-deficient athymic rats Injections into white matter of normal rats indicated that ⌬E1/E3 adenoviral vectors could be used to deliver genes to oligodendrocytes. However, the robust immune response elicited limited the value of this approach for assessing their experimental potential. It was therefore decided to examine the effects of adenoviral vectors in the absence of an immune response by injecting virus into athymic recipients ( Table 1 , group 2).
In an initial series of experiments virus was injected at a dose of 10 9 p.f.u./l (group 2a). Although labelled cells were identified within the dorsal funiculus over a length of at least 8 mm at 7 dpi, there was also evidence of axonal degeneration, primary demyelination and macrophage infiltration over most of this area (Figures 10, 11 and 12). A particularly interesting feature of these lesions was presence of areas where abnormal oligodendrocyte and myelin pathology were present in the absence of significant numbers of macrophages, the latter being especially apparent in areas where demyelination had occurred. This suggested that the inflammatory response was a consequence of, rather than a mediator of oligodendrocyte pathology. At 40 dpi this area of the dorsal funiculus contained oligodendrocyte and Schwann cell remyelinated axons, the latter usually occurring as a result of astrocyte damage ( Figure 13 ). 18 Even at this time, a small number of labelled cells could be detected at the edges of the damaged area and around the ependymal layer of the central canal. This contrasts with the absence of labelled cells at 40 dpi following injection into normal white matter (group 1), suggesting that the absence of long-term expression of adenoviral transgene in normal animals was most likely due to an immune-mediated loss of infected cells.
In order to establish whether these cytopathic effects were due to the injection of a high viral titre, a further experiment was undertaken in which doses of 10 8 , 10 7 and 10 6 p.f.u./l (made by dilution of the original stock) were injected (group 2b). These injections revealed a clear dose response effect in terms of the number of transgene expressing cells, which was estimated by counting the numbers of blue nuclei in sections sampled at 1 mm intervals. More blue cells were seen in a greater number of blocks with increasing viral titre (Figure 15 ), and blue staining of processes was only seen at the highest titre of 10 8 p.f.u./l. The numbers and distribution of labelled cells did not change significantly with differences in survival time. Only mild cytopathic effects (occasional demyelinated axons and hypertrophied astrocyte processes) were observed in the white matter following injection of 10 8 p.f.u./l, and no cytopathic effects were observed following injection of the two lower titres. Thus, this experiment indicated that a titre of 10 8 p.f.u./l resulted in a high rate of infectivity and expression, while higher titres induced significant cytopathic effects and lower titres a significant decrease in the efficiency of the number of cells expressing the transgene.
AdCNTF in white matter of immune-deficient athymic rats In order to establish if the cytopathic effects of AdlacZ were due to the expression of the LacZ transgene, we next injected the same ⌬E1/E3 adenoviral vector but carrying an alternative transgene (Table 1, group 3). For this purpose we used a vector expressing CNTF, a neurocytokine that is per se not cytopathic and that has a variety of effects on the oligodendrocyte lineage that may be relevant to both oligodendrocyte injury and repair. 14, 15 AdCNTF was injected at titres of 1. changes in the white matter similar to those seen following injection of AdlacZ at 10 9 p.f.u./l, from which it was apparent that the protective effects of CNTF on oligodendrocytes could not offset the cytopathic effects of the adenoviral vector. At 5 dpi there was evidence of demyelination, axonal degeneration and macrophage infiltration. At 14 dpi both Schwann cell and oligodendrocyte remyelination was evident (Figure 14) . There was considerably less damage to the white matter following injection of virus at 1.2 × 10 7 , where only a small area of myelin vacuolation was observed. No pathological changes were observed in the white matter following injection of the lowest titre of 1.2 × 10 6 p.f.u./l.
Discussion
The use of adenoviral vectors in the brain has largely focused on their potential for gene delivery to neurons and in particular the possibility of correcting neurodegenerative pathology by the provision of therapeutic molecules. 5, 7, 19 The ability of these vectors to deliver genes to the glial component of the CNS has received less attention, although gene expression in astrocytes, microglia, 5,7,13 ependymal cells 20, 21 and Schwann cells of the PNS 22, 23 has been recorded. The ability of adenoviral vectors to infect oligodendrocytes has been demonstrated in vitro 7, 24 and in in vivo, 6 and indeed the expression of trangene can be targetted to these cells by the use of the oligodendrocyte-specific promoter of the myelin-basic protein gene. 8 Thus, an additional use of these vectors in experimental neuropathology is in their potential for gene delivery to white matter and in particular for understanding pathological responses of the oligodendrocyte. For example, adenoviral vectors could be used for testing the effects of putative demyelinating molecules about which there is current controversy, such as tumour necrosis factor-␣ [25] [26] [27] [28] or fibroblast growth factor-2, 29,30 or of putative remyelination-enhancing molecules following demyelination. [31] [32] [33] However, given the now well-documented immunogenic and cytopathic effects of adenoviral vectors it is pertinent to address the extent to which these properties limit the use of these vectors for studying mechanisms of white matter pathology or for the therapy of genetic disorders of oligodendrocytes.
In this study we have shown that adenoviral vectors are an efficient means of gene transfer to oligodendrocytes following direct injection into white matter, and might therefore be suitable tools for understanding the in vivo biology of these cells by means of gene manipulation. A further potential use of adenoviral vectors demonstrated by the current experiments could be in the study of oligodendrocyte morphology. The extensive filling of the oligodendrocyte cytoplasm with X-gal reaction product following injection of AdlacZ reveals the in vivo morphology of these cells in much the same manner as can be achieved by direct injection of labels such as lucifer yellow or HRP. 34 We also confirm the observations that adenoviral vectors can be used for gene transfer into other CNS cells including neurons, astrocytes and ependymal cells (the latter being a means by which secreted transgene products might be widely distributed around the CNS by way of the CSF). [5] [6] [7] 20, 21, 35 The labelling of axons of the ventral horn motoneurons described in this study and of cell bodies of substantia nigra neurons described by Akli and co-workers 5 indicates that axonal pathways might be used to deliver gene products to specific sites remote from the point of virus injection.
The use of these vectors is not however, without difficulties. In normal white matter a high viral titre elicits an extensive and tissue damaging immune response which leads to the loss of transgene expressing cells. This T cellmediated immune response, initially mainly a CD4 + response and subsequently mainly a CD8 + response, 36 appears to be directed predominantly against viral proteins since vectors that do not express transgene are equally immunogenic. 9, 37 This problem can be overcome by immunosuppression, 38 or by using T-lymphocytedeficient animals. 13, 36, 39 The absence of an immune response unmasks the direct cytopathic effects of adenoviral vectors when injected at high titres. In CNS white matter, these involve oligodendrocyte death and hence demyelination. Our results suggest that this is a direct consequence of infection since oligodendrocyte pathology occurs before the subsequent macrophage inflammatory response, provoked by the presence of myelin debris generated by oligodendrocyte death and demyelination. The extensive Schwann cell remyelination that occurs in these areas of demyelination indicates that astrocytes are also damaged in areas where high titres of virus are injected. Cytopathic effects on cultured astro- 
u./l AdlacZ into athymic rats (group 2a). Blue cells can be identified (arrow), but there is widespread damage to the white matter involving demyelination and axonal degeneration with the formation of myelin figures.
Toluidine blue-stained resin section ×450. cytes have been reported using the same AdlacZ vector with titres exceeding 10 6 p.f.u./l. 35 However, astrocytes, which are more resistant to cytopathic effects than neurons, 13 appear less vulnerable to the cytopathic effects of adenoviral vector infection than do oligodendrocytes. In our study, the pathology induced was similar regardless of the transgene since demyelinating lesions were induced following injection of vectors that expressed the enzyme ␤-galactosidase and the neurocytokine CNTF. Interestingly, the protective effects of CNTF on oligodendrocytes could not offset the cytopathic effects of the adenoviral vector. Decreasing the titre of the injected virus resulted in a significant decrease in the degree of cytopathogenicity, but also led to a decrease in the number of cells expressing detectable levels of transgene product. Thus, the use of adenoviral vectors in the study of white matter pathology involves a trade-off between the extent to which gene transfer is achieved and the cytopathic effects induced by the procedure. Indeed, the cytopathic effects of high viral titres are such that adenoviral vectors may find alternative roles in neuropathology. For example, the demyelinating capacity of high viral titres might serve as a useful alternative experimental model of demyelination of those currently available. Adenoviral vectors have also been suggested as a means of delivering 'suicide genes' in the control of neoplasms such as glioblastomas. 40 The cytopathic effects of these vectors at high titres may augment, or even substitute for the cellkilling effects of suicide gene expression. Efficient methods of gene delivery to oligodendrocytes in tissue culture have been developed. 24 In the future, improved viral vectors that are less immunogenic and less cytopathic, such as adenoviral vectors deleted in more or all viral genes, 41 adeno-associated virus vectors 42 or lentiviral vectors 43 should be tested for gene delivery to oligodendrocytes in vivo.
Materials and methods

Adenoviral vectors
The preparation of the E. coli LacZ-expressing adenoviral vector (AdlacZ) has been described elsewhere. 44 In brief, the vector is deleted in the E1 and E3 regions and contains the E. coli LacZ gene (encoding for ␤-galactosidase) followed by the SV40 nuclear localisation signal sequence which targets expression to the nucleus. Expression of LacZ is driven by the LTR RSV promoter. The construction and preparation of the CNTF-expressing adenoviral vector (AdCNTF), which contains the same ⌬E1/E3 adenovirus backbone and LTR RSV promoter, has been described elsewhere. 45 Viral stocks were produced and titred on 293 cells with a yield of up to 3 × 10 12 p.f.u./ml. Aliquots of the original stock were used for all experiments. These stocks were not tested for endotoxin or replication-competent adenovirus that may have augmented the immune response following injection into the spinal cords of normal rats.
Animal injections
Injections of either AdlacZ or AdCNTF were made into the spinal cord white matter of either adult (Ͼ3 months) Sprague-Dawley rats or athymic nude rats. The animals were anaesthetised with halothane and under sterile conditions, a laminectomy was performed at the level of the first lumbar vertebra. One microlitre of a solution of virus was injected into the dorsal funiculus using a glass micropipette attached to a 10 l Hamilton syringe. A summary of the injections made and survival times is presented in Table 1 .
Tissue processing
Those animals from which tissue was processed for histology were killed by aortic perfusion with a solution of 1% glutaraldehyde, 3% paraformaldehyde and 2 mm MgCl 2 (groups 1 and 2, see Table 1 ) or with 4% glutaraldehyde (group 3) under deep pentobarbitone-induced anaesthesia. The fixed cord was removed and cut into eight 1 mm coronal blocks that encompassed the injected area. In order to detect the expression of AdlacZ ␤-galactosidase the blocks in animals from groups 1 and 2 were washed three times (5 min) in PBS, twice (5 min) in PBS and 2 mm MgCl 2 , once in NP40 detergent (10 min), and then incubated overnight at 37°C in the dark in a solution containing the ␤-galactosidase reaction sub- strate, X-gal. The blocks were then washed three times (5 min) in PBS, osmicated, dehydrated through ascending alcohols, and embedded in TAAB resin using a standard protocol. Tissue blocks from animals in group 3 were processed into resin in a similar fashion. Sections were cut from each block, which were either stained with alkaline toluidine blue (1 m sections) or left unstained (2 m sections) and examined by light microscopy. Selected regions were trimmed and ultrathin sections cut for electron microscopy. Selected blocks were re-sectioned at 1 m on to Vectabond-coated slides for glial fibrillary acidic protein (GFAP) immunocytochemistry. Resin sections were etched in sodium ethoxide and de-osmicated in hydrogen peroxide before incubating with anti-GFAP antibody at 1:200 for 1 h at room temperature. The bound antibody was visualised by immunoperoxidase staining using diaminobenzidine substrate (Vectastain Elite ABC kit).
Figure 16 RT-PCR detection of adenoviral CNTF expression after AdCNTF injection into athymic rat spinal cord white matter (group 4). (a) The
Reverse transcription (RT)-PCR analysis
In order to carry out PCR analysis of expression of adenoviral CNTF following injection of AdCNTF, total RNA was extracted from animals in group 4 as follows. Tissue was homogenized (Polytron homogenizer) in guanidium thiocyante buffer, and total RNA pelleted by ultracentrifugation on a caesium chloride cushion. After resuspension in Tris-EDTA buffer containing 0.1% SDS, the RNA was precipitated in 100% ethanol and sodium acetate at 4°C overnight and collected by centrifugation at 12 000 g at 4°C for 10 min. The RNA was diluted in diethyl pyrocarbonate-treated water. One microgramme of RNA was reverse transcribed into cDNA with RT-MMLV (Gibco, Maryland, USA). Adenoviral NGF/CNTF transcripts were amplified by 30 cycles of RT-PCR (30 s 95°C; 30 s, 55°C; 1 min, 72°C) using primers homologous to the NGF leader sequence (5Ј-AGCTCACCTCAGTGTCTGGG) and to CNTF exon 2 (5Ј-ACCATCCACTGAGTCAAGGC) in reaction buffer (New England Biolabs, Beverly, MA, USA) containing 10% DMSO and 1.5 mm MgCl 2 (see Figure 16 ). Control RT-PCR reactions were carried out with primers homologous to ␤-actin exon 1 (5Ј-CGTGGGCGCCCCTAGGCACCA) and exon 2 (5Ј-TTGGCCTTAGGGTTCAGAGGGG). The RT-PCR products were electrophoresed on agarose gels and stained with ethidium bromide.
